Dopamine D2 Receptor Antagonists
"Dopamine D2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.
| Descriptor ID |
D065127
|
| MeSH Number(s) |
D27.505.519.625.150.175.500 D27.505.696.577.150.175.500
|
| Concept/Terms |
Dopamine D2 Receptor Antagonists- Dopamine D2 Receptor Antagonists
- Receptor Antagonists, Dopamine D2
- Dopamine D2 Antagonists
- Antagonists, Dopamine D2
- D2 Antagonists, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine D2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Dopamine D2 Receptor Antagonists".
This graph shows the total number of publications written about "Dopamine D2 Receptor Antagonists" by people in this website by year, and whether "Dopamine D2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine D2 Receptor Antagonists" by people in Profiles.
-
Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat Commun. 2021 06 09; 12(1):3478.
-
Liability and Failure to Warn a Patient. Continuum (Minneap Minn). 2019 Aug; 25(4):1141-1144.
-
Investigational dopamine antagonists for the treatment of schizophrenia. Expert Opin Investig Drugs. 2017 Jun; 26(6):687-698.
-
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016 Jan; 56(1):153-61.
-
Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists. J Med Chem. 2014 Apr 24; 57(8):3450-63.
-
Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl). 2005 Mar; 178(2-3):347-50.
-
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm (Vienna). 2000; 107(10):1165-73.